Intravitreal Antibiotics after Cataract Surgery in a Patient with Penicillin Anaphylaxis and Therapeutic Warfarin

Standard therapy

Intravitreal vancomycin 1 mg/0.1 mL plus ceftazidime 2.25 mg/0.1 mL is the standard initial regimen for post-cataract endophthalmitis because it covers gram-positive organisms including MRSA and gram-negative organisms respectively.

Penicillin anaphylaxis and ceftazidime

Cross-reactivity between penicillin and third-generation cephalosporins such as ceftazidime is low, generally around 1%, because the side-chain structures differ. A history of anaphylaxis mandates caution, not automatic avoidance of every cephalosporin. In this sight-threatening situation, ceftazidime is reasonable with informed consent, resuscitation readiness, and observation, since the alternative carries greater ocular risk.

Amikacin

Amikacin 0.4 mg/0.1 mL is an alternative gram-negative agent, but it has a narrower safety margin and is associated with macular infarction and retinal toxicity, especially at higher doses. It is not a routine substitute when ceftazidime is available and the cross-reactivity risk is low.

Additional reasoning

If the patient refuses any beta-lactam, options include culture-directed therapy after vitreous tap, or an alternative agent with infectious disease input. Do not omit gram-negative coverage without a plan.

Concentration and volume

• Vancomycin must be 1 mg in 0.1 mL, not 1 g or 10 mg. Ceftazidime must be 2.25 mg in 0.1 mL. Decimal errors are a well-recognized cause of retinal toxicity.
• Use preservative-free powder; benzyl alcohol and other preservatives are toxic to the retina.
• Check osmolality and pH of the final preparation; formulations should be isotonic and near neutral pH.

Compounding

• Prepare in a sterile pharmacy or using a validated protocol; label with drug, concentration, volume, and expiry.
• Draw up separate syringes for vancomycin and ceftazidime rather than mixing unless compatibility is documented.
• Inspect for particulate matter; do not use a cloudy solution.

Administration

• Use a dedicated needle and measure the 0.1 mL volume carefully; a short 30-gauge needle is preferred.
• Perform a proper povidone-iodine preparation and sterile drape.
• After injection, check light perception and fundus perfusion; monitor for intraocular pressure spike.

Why this matters

Retinal toxicity from intravitreal antibiotics is dose-related and often irreversible. The safeguards are not administrative clutter; they directly prevent toxic retinopathy.

Warfarin

An intravitreal injection is a low-bleeding-risk procedure. An INR of 2.8 is within the therapeutic range for atrial fibrillation, and routine reversal is not required and would expose the patient to thromboembolic risk. Proceed with gentle technique; avoid unnecessary conjunctival dissection. Check the INR again only if there is active bleeding or the value is above the usual therapeutic range. If a pars plana vitrectomy is required, coordinate with the patient's physician but do not reverse solely for the injection.

Vitrectomy versus tap

For post-cataract endophthalmitis presenting at 72 hours with hand-motion vision and dense vitritis, vitreous tap and intravitreal antibiotics are appropriate initial management if there is no corneal melt or worsening despite treatment. Pars plana vitrectomy is considered when:

• vision is no light perception,
• there is rapid deterioration despite intravitreal antibiotics,
• the vitreous is too dense for adequate antibiotic diffusion, or
• the clinical course suggests a virulent organism.

Reasoning

The decision is driven by disease severity and expected drug penetration, not by the INR alone. If vitrectomy is chosen, it can proceed at therapeutic INR with careful hemostasis; the benefit of source control outweighs bleeding risk in a blind, painful eye.